Docs told to avoid 1 flu shot brand for small kids

Aug 05, 2010 By MIKE STOBBE , AP Medical Writer

(AP) -- A government panel is recommending doctors steer clear of giving one brand of flu vaccine to young children this year because of problems with it in Australia and New Zealand.

At issue is a flu shot made by CSL Biotherapies, an Australian company. There was an unexplained higher rate of fevers and seizures in children who got the vaccine this spring in those countries.

The Australian company is making vaccine for Americans this fall, but only a small portion of the 170 million doses.

On Thursday, the Advisory Committee on Immunization Practices said doctors should avoid using the Australian in children under 8, especially in those under 5.

U.S. officials say they have not seen similar problems with other vaccines.

Explore further: FDA warns of compounded drug recall by Texas firm

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

Possible seasonal shot seen for bird flu

May 04, 2006

A seasonal flu shot against a possible bird flu pandemic is reported to be under consideration by U.S. public health officials at a Singapore conference.

FDA approves new swine flu vaccine

Sep 15, 2009

(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...

Recommended for you

EU regulator: Morning-after pill OK for all women

7 hours ago

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

11 hours ago

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

Zydelig approved for three types of blood cancer

12 hours ago

(HealthDay)—Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) ...

Journal raises concern about blood-thinning drug

Jul 23, 2014

A medical journal raised concerns Wednesday about a blood-thinning drug widely used by people at risk of stroke, accusing its manufacturer of concealing safety data and regulators of laxness.

User comments : 0